Target intelligence / Profile preview

Keratocan (KERA)

Target
KERA
Molecular classification
Proteoglycan, Small leucine-rich proteoglycan (SLRP) family, Extracellular matrix protein
01

Overview

Keratocan is a secreted extracellular matrix proteoglycan, encoded by the *KERA* gene, that binds to keratan sulfate chains and is primarily expressed in the cornea[1][3][4][10]. It belongs to the small leucine-rich proteoglycan (SLRP) family and is essential for the organization of collagen fibrils and maintaining the stromal matrix architecture, thereby ensuring corneal transparency and correct curvature[1][2][3]. Mutations in the *KERA* gene can result in cornea plana 2, a rare autosomal recessive disorder characterized by flattened corneal curvature and impaired vision[1][2][3][4][6][9][10]. There is currently no evidence that keratocan is a direct target of any pharmaceutical drugs or used as a clinical biomarker.

Other names
KERACNA2KTNSLRR2Bkeratocan proteoglycankeratan sulfate proteoglycan keratocan
02

Biological functions

Maintenance of corneal transparencyOrganization of collagen fibrilsRegulation of stromal matrix structure
03

Disease associations

Cornea plana 2 (autosomal recessive)Congenital cornea plana

Beyond the preview

Go deeper on Keratocan (KERA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratocan (KERA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call